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E mpyema is one of the potential complications following an extrapleural pneumonectomy,  which 
is currently considered the treatment of choice for 
selected patients with resectable malignant pleural 
mesothelioma (MPM) [1].  Empyema is a major event 
in the postoperative course,  with a substantial mortal-
ity rate.  In cases of an apparent bronchopleural ﬁs-
tula (BPF),  it is usually conceded that an aggressive 
surgical treatment such as a re-thoracostomy is 
required for closure of the ﬁstula,  with lavage and 
drainage of the pleural space [2].
　 However,  some reports have suggested that thora-
coscopy can be a valuable approach for patients pre-
senting with early-stage (i.e.,  exudative or ﬁbrinopuru-
lent) empyema [3,4] or even post-pneumonectomy 
empyema (PPE),  with or without a minor bronchop-
leural ﬁstula [5,6].  It has also been reported that a 
thoracoscopic approach can be eﬀective for late-stage 
(i.e.,  organized and chronic) PPE [6].  Here we 
describe the successful treatment of our patient with 
late-stage empyema,  for whom we used a thoraco-
scopic approach following an extrapleural pneumonec-
tomy.
Case Report
　 A 65-year-old Japanese man with a history of 
cholelithiasis was diagnosed with right MPM,  sarco-
matoid type,  cT3N0M0 stage III,  and a right 
extrapleural pneumonectomy was performed in 2013 
(Fig. 1),  with reconstruction of the diaphragm and the 
pericardium with a Gore-Tex® polytetraﬂuoroethylene 
(PTFE) patch through the fourth intercostal thoracot-
omy.  The postoperative course was uneventful except 
for wound dehiscence that was treated with debride-
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We present the case of a 65-year-old Japanese man diagnosed with chronic empyema (without a bron-
chopleural ﬁstula) that occurred 7 months after he underwent an extrapleural pneumonectomy for 
right malignant pleural mesothelioma (MPM).  Following thoracic drainage and irrigation for 1 month,  
we performed surgery by a thoracoscopic approach,  in light of his general condition.  We performed 
debridement and removal of the Gore-Tex polytetraﬂuoroethylene (PTFE) patch that had been used 
for the reconstruction of the diaphragm and the pericardium.  The empyema had not relapsed when he 
died from recurrence of the MPM at 4 months after the thoracoscopic surgery.  This patientʼs case 
suggests that thoracoscopic debridement and patch removal can be a therapeutic option for not only 
early-stage (exudative or ﬁbrinopurulent) empyema but also late-stage (organized and chronic) empy-
ema without a bronchopleural ﬁstula,  particularly for patients in poor general condition.
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Fig.  1　 Pathological ﬁndings of a surgical specimen. A,  The gross appearance showed pleural thickening and encasement of lung 
parenchyma of the right lung; B,  The microscopic ﬁndings showed proliferation of spindle-shaped cells with elongated nuclei.
Fig.  2　 Chest CT scan on readmission.  A,  A subcutaneous abscess had formed; B,  The subcutaneous abscess drained to the thoracic 
cavity through the 5th intercostal ﬁstula.
Fig.  3　 Intraoperative ﬁndings.  A,  Thoracoscopic surgery was 
performed under good observation of the entire thoracic cavity; B,  
Tight adhesion was formed under the PTFE patches.  The medias-
tinum was adequately ﬁxed and did not need to be reconstructed.
ment and resuture.  Adjuvant chemotherapy using 
carboplatin (75 mg/m2) and pemetrexed (500 mg/m2) 
had been performed subsequent to the adjuvant radio-
therapy (2 Gy/day; total 54 Gy),  but it was canceled 
after one course because his performance status 
declined from 1 to 2.
　 Seven months after the pneumonectomy,  he was 
readmitted to our hospital because of fever and wound 
dehiscence.  An image analysis with an enhanced CT 
scan of the chest revealed no evidence of tumor recur-
rence.  An infectious eﬀusion had discharged from the 
wound and a subcutaneous abscess had formed (Fig. 
2A); the abscess also drained to the thoracic cavity 
through the 5th intercostal ﬁstula (Fig. 2B).  Chest 
tube drainage was performed through the ﬁstula in the 
subcutaneous abscess.  The anaerobic Gram-positive 
coccus Finegoldia magna was detected in the pleural 
eﬀusion.
　 Because no air leakage was observed,  we made the 
diagnosis ʻchronic empyema without a BPF. ʼ We initi-
ated an intravenous administration of antibiotics (tazo-
bactam/piperacillin 4.5 g×3) and irrigation using 
urokinase to treat the patientʼs empyema [7]; how-
ever,  the level of C-reactive protein and the white 
blood cell count did not decrease completely after 1 
monthʼs irrigation.  This condition was regarded as 
refractory chronic empyema because the PTFE patch 
that was tightly sutured to the thoracic cavity was a 
foreign body,  and its removal was mandatory to con-
trol his empyema.
　 Although we considered an open-window thoracot-
omy as the treatment of choice,  considering the 
patientʼs poor general condition,  we chose a thoraco-
scopic approach.  On day 30 after rehospitalization,  
we performed a thoracoscopic debridement and Gore-
Tex patch removal.  A thoracoscopic port was placed 
in the 8th intercostal space on the midaxillary line,  
and two ports were placed in the 5th intercostal ﬁstula 
and the 4th intercostal anterior axillary line.  With 
these access ports for thoracoscopic surgery,  we suc-
cessfully removed the PTFE patch and the remaining 
infected granulation tissue under clear vision of thora-
coscopy throughout the procedure.  At the end of the 
surgery,  we irrigated the cavity of the empyema with 
saline,  and a chest tube was inserted into the pleural 
cavity through the thoracoscopic wound.
　 The intraoperative cytology of pleural eﬀusion 
showed no existence of malignant cells.  He was extu-
bated on the 5th postoperative day and treated with 
antibiotics intravenously until the 7th postoperative 
day.  He was discharged 14 days after the thoraco-
scopic debridement.
　 Unfortunately,  recurrence of the MPM was identi-
ﬁed in course and the patient chose to receive the best 
supportive care,  considering his poor general condi-
tion.  The empyema had not relapsed when he died 4 
months after the thoracoscopic surgery.
Discussion
　 Empyema of the pleural space occurs in 2–15  of 
patients after a pneumonectomy [8],  and in 2.4  of 
patients after an extrapleural pneumonectomy at expe-
rienced institutions [9].  The management of PPE 
depends on the presence or absence of a BPF and 
whether it presents early or late.  Some authors have 
stated that when a BPF is absent or only minor,  ear-
ly-stage PPE can be treated with thoracoscopic drain-
age and lavage [5,6].  However,  in the case of late-
stage PPE,  the organization of ﬁbrin in the thoracic 
cavity progresses with infectious tissue,  and this 
requires more aggressive management such as an 
open-window thoracostomy [5,9].
　 In our patientʼs case,  the diagnosis of PPE was 
made 7 months after he underwent an extrapleural 
pneumonectomy.  We initially felt that he thus needed 
to undergo an open-window thoracostomy; however,  
his general condition was so poor that a less invasive 
procedure was worth considering.  Studies report that 
in the absence of a BPF,  open-window thoracostomy 
is a questionable option because of its high morbidity,  
reported to be up to 29  [10],  with a recurrence rate 
of infection of up to 38  [11].  However,  Tong et al.  
reported that thoracoscopic surgery for empyema had 
many advantages such as shorter hospital stays and 
lower rates of postoperative complications and mortal-
ity compared to conventional open thoracostomy [12].  
Considering these reports,  we eventually selected a 
thoracoscopic approach to successfully control our 
patientʼs empyema.
　 In his surgery,  the thoracic cavity was relatively 
clear with a relatively small amount of infected granu-
lation because of the irrigation using urokinase.  We 
therefore focused on the removal of the PTFE patch 
because we suspected that it was probably responsible 
for his refractory empyema.  Lambros Zellos et al.  
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reported that in early-stage empyema the patch can be 
left in place,  but patients with late-stage empyema 
require patch removal to control the empyema [9].
　 We were able to remove our patientʼs PTFE patch 
with the thoracoscopic surgery,  which makes the pro-
cedure easy under good observation of the entire tho-
racic cavity (Fig. 3A).  Observation using a thoraco-
scope is very helpful,  because with it the surgeon can 
remove not only a PTFE patch but also infectious 
granulation without residual materials.  In addition,  
chronic infectious tissue is sometimes very diﬃcult to 
remove,  but a thoracoscopical procedure works well 
for this condition.
　 Of note,  we did not need to perform a reconstruc-
tion to prevent herniation of the abdominal contents,  
cardiac herniation,  or mediastinal shift,  because 7 
months had passed since the initial surgery and the 
adhesions that had formed under the patches were 
strong enough to prevent these complications (Fig. 
3B).
　 As a limitation of this report,  one case experience 
alone is not enough to conclude that a thoracoscopic 
approach is useful for the majority of cases with a 
similar clinical situation.  However,  our experience 
suggests that thoracoscopic debridement and patch 
removal should be considered for patients with a poor 
performance status and late-stage empyema without a 
bronchopleural ﬁstula.
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